Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Outcomes of Acute Myeloid Leukemia Patients Presenting in a Tertiary Care Hospital: A Developing Country Experience

AML - 1014

Outcomes of Acute Myeloid Leukemia Patients Presenting in a Tertiary Care Hospital: A Developing Country Experience

Afsheen Liaqat

Poster Presenter: Afsheen Liaqat

Thumbnail for Antifungal Prophylaxis in Acute Promyelocytic Leukemia: The Azole Dilemma During Arsenic Trioxide Therapy

AML - 1015

Antifungal Prophylaxis in Acute Promyelocytic Leukemia: The Azole Dilemma During Arsenic Trioxide Therapy

Christian Farag

Poster Presenter: Christian Farag

Thumbnail for Temporal Improvements in Overall Survival Among Patients With Acute Myeloid Leukemia Across Racial and Ethnic Groups in the United States: A Population-Based Analysis of Survival Trends from 2000 to 2023

Previous 1...20 21 22 23 24 25 26...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

AML - 1018

Temporal Improvements in Overall Survival Among Patients With Acute Myeloid Leukemia Across Racial and Ethnic Groups in the United States: A Population-Based Analysis of Survival Trends from 2000 to 2023

Waleed Dita

Poster Presenter: Waleed Dita

Thumbnail for CR/CRi and MRD Outcomes With Intensive vs Low-Intensity Chemotherapy in AML: A Single-Center Retrospective Analysis

AML - 1020

CR/CRi and MRD Outcomes With Intensive vs Low-Intensity Chemotherapy in AML: A Single-Center Retrospective Analysis

Bret Miller

Poster Presenter: Bret Miller

Thumbnail for Transplant Outcomes and Rates of Graft-Versus-Host Disease for FLT3-ITD Acute Myeloid Leukemia by Graft Source in the Era of Posttransplant Gilteritinib Maintenance

AML - 1029

Transplant Outcomes and Rates of Graft-Versus-Host Disease for FLT3-ITD Acute Myeloid Leukemia by Graft Source in the Era of Posttransplant Gilteritinib Maintenance

Joseph Mort

Poster Presenter: Joseph Mort

Thumbnail for Phenotype-Specific Safety Differences Between Gilteritinib and Midostaurin in AML: A FAERS Analysis Highlighting Differentiation Syndrome Signal

AML - 103

Phenotype-Specific Safety Differences Between Gilteritinib and Midostaurin in AML: A FAERS Analysis Highlighting Differentiation Syndrome Signal

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Comparative Inpatient Mortality and Hospitalization Burden in AML, ALL, and DLBCL: A Nationwide Analysis, 2016-2020

AML - 1032

Comparative Inpatient Mortality and Hospitalization Burden in AML, ALL, and DLBCL: A Nationwide Analysis, 2016-2020

Srijani Thannir

Poster Presenter: Srijani Thannir

Thumbnail for Plasma Cytokeratin-18 Fragment in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia

AML - 107

Plasma Cytokeratin-18 Fragment in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia

Mostafa El Razzaz

Poster Presenter: Mostafa El Razzaz

Thumbnail for Pretransplant Measurable Residual Disease and Survival After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: Does Donor Type Change the Risk?

AML - 1079

Pretransplant Measurable Residual Disease and Survival After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: Does Donor Type Change the Risk?

Aakriti Adhikari

Poster Presenter: Aakriti Adhikari

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors